Archie Bleyer,Brian Barnes,Elizabeth Stuyt et al.
Archie Bleyer et al.
Background and objectives: Since 2019, the drug overdose death rate among adolescents 14-18 years of age in the United States more than doubled. That cannabis legalization may have contributed to this tragedy is investiga...
Associations between big five personality dimensions and lifetime use of cannabis [0.03%]
五大人格特质与终生使用大麻之间的关系
Tanya Jain,Michelle Patriquin,Marsal Sanches
Tanya Jain
Background and objectives: With the rise in cannabis use over the last couple of decades and shifting social views around drug use, the characterization of potential predictors for the development of cannabis use disorder...
Interactive effects of ARRB2 and CHRNA5 genetic polymorphisms on cognitive function in Chinese male methamphetamine use disorder patients [0.03%]
ARRB2和CHRNA5基因多态性交互作用对中国男性甲基苯丙胺依赖患者认知功能的影响
Linjun Jiang,Dongmei Wang,Yang Tian et al.
Linjun Jiang et al.
Background and objectives: Both β-arrestin2 and nicotinic acetylcholine receptor (nAChR) have been implicated in cognitive processes, particularly in relation to psychiatric disorders, including addiction. Previous studi...
Profiles of polysubstance use among people reporting past 12-month sleep-motivated nonmedical use of prescription tranquilizers/sedatives [0.03%]
过去12个月因睡眠原因非医疗使用镇静/安眠类处方药物的人群的多药滥用特征分析
Alyssa M Falise,Parvathy Prasanna Surendran,Carolin C Hoeflich et al.
Alyssa M Falise et al.
Background and objectives: Nonmedical use of prescription tranquilizers/sedatives (NMUPTS) is associated with a 15-times increased likelihood of polysubstance use (PSU). This is correlated with an increased risk for use d...
Patient-provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study [0.03%]
医务人员与患者关于大麻治疗用途的互动因医务人员类型而异：一项试点研究
Jivan Achar,Alan J Budney,Cara A Struble
Jivan Achar
Background and objectives: Limited evidence guides the efficacy and safety of cannabis for therapeutic purposes (CTP). Healthcare providers lack requisite knowledge to advise and support patients. This study aimed to desc...
Substance use and psychiatric phenotypes of youth experiencing homelessness: A cluster analysis [0.03%]
集群分析无家可青年的物质使用和精神特征 phenotype
Colin W Burke,Sylvia Lanni,Bettina B Hoeppner et al.
Colin W Burke et al.
Background and objectives: Due to the complex interactions of psychopathology, psychosocial stressors, and risk behaviors, characterizing high-risk phenotypic groups of transitional-age youth experiencing homelessness (TA...
Trends in racial/ethnic and geographic disparities in substance use disorders mortality in the United States, 2000-2019 [0.03%]
2000至2019年美国物质使用障碍死亡率的种族、民族和地区差异趋势
Akshaya S Bhagavathula,Theodoros Daglis,Yoshito Nishimura
Akshaya S Bhagavathula
Background and objectives: Substance use disorders (SUD) are a major public health concern in the United States. This study examined racial/ethnic and state-level disparities in SUD mortality in the United States from 200...
Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era [0.03%]
新形势下的应对策略：芬太尼时代下成瘾医学专家对阿片类药物使用障碍治疗和政策挑战的看法
Jeremy Weleff,Nicholaus J Christian,James X Wang et al.
Jeremy Weleff et al.
Background and objectives: Amidst increasing opioid-related overdoses in the USA, opioid use disorder (OUD) treatment has seen few novel treatments emerge. High-potency synthetic opioids (HPSOs) have altered clinical appr...